Amryt Pharma PLC (LSE:AMYT) - Share price - Overview

Stock Report

Amryt Pharma PLC AMYT

Last Price
GBX21.75

Day Change
0.00|0.00%

As of 22/09/2017
16:29:39 BST | GBX
Minimum 15 Minutes Delay.

Last Close21.75p
Day Range21.08 - 22.00
Mkt Cap45.31Mil
52-Wk Range13.44 - 29.50
Yield %0.00
ISINGB00BDD1LS57
Volume191,243
P/E-7.26
P/S32.13
P/CF-7.10

Share Price

Total Returns 22/09/2017

 Chg (%)  
More ...
Amryt Pharma PLC3.57 
FTSE 100 TR GBP-0.82
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.001.11
Operating Profit-1.85-1.31-6.29
Net Profit-1.61-1.25-6.39
Reported EPS-4.39-2.90-3.92
Balance Sheet
Current Assets10.529.519.89
Non Current Assets31.040.0045.84
Total Assets41.559.5155.73
Current Liabilities7.900.333.03
Total Liabilities7.940.3327.53
Total Equity33.619.1828.20
Cash Flow
Operating Cash Flow-1.30-1.40-5.01
Net Change in Cash-9.01-2.476.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/03/2017PurchaseMr. Markus Ziener21.50100,00021,500.00

Company Profile

Amryt Pharma PLC is a specialty pharmaceutical company. The company is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

1142 of 1836 Companies

Index

FTSE AIM All Share

Outlook

(04/09/2017) ceo - "...we remain confident of continuing strong progress over the remainder of 2017 and into 2018"

Next Event 31/12/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0013.166.87
Div Yld (E)0.003.994.18
PEG (E)0.000.760.90
ROCE40.58194.20214.15
Op Mrgn-432.46-3.46-38.07
EPS Grwth0.0021.6319.05
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanHarry Stratford
Chief Executive OfficerDr. Joseph Wiley
Chief Financial Officer, COO & CSRory Nealon
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.